Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis
NCT00172003
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Renal Cell Cancer
Neoplasm Metastasis
Interventions
DRUG:
Zoledronic acid
Sponsor
Novartis Pharmaceuticals